Cargando…

Dosimetry and efficacy of a tau PET tracer [(18)F]MK-6240 in Japanese healthy elderly and patients with Alzheimer’s disease

OBJECTIVE: A new tau PET tracer [(18)F]MK-6240 has been developed; however, its dosimetry and pharmacokinetics have been published only for a European population. This study investigated the safety, radiation dosimetry, pharmacokinetics and biodistribution of [(18)F]MK-6240 in Japanese elderly subje...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ohnishi, Akihito, Akamatsu, Go, Ikari, Yasuhiko, Nishida, Hiroyuki, Shimizu, Keiji, Matsumoto, Keiichi, Aita, Kazuki, Sasaki, Masahiro, Yamamoto, Yasuji, Yamane, Tomohiko, Senda, Michio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902412/ https://www.ncbi.nlm.nih.gov/pubmed/36411357 http://dx.doi.org/10.1007/s12149-022-01808-7

Ejemplares similares

Voxel-based statistical analysis and quantification of amyloid PET in the Japanese Alzheimer’s disease neuroimaging initiative (J-ADNI) multi-center study
por: Akamatsu, Go, et al.
Publicado: (2019)

Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue
por: Aguero, Cinthya, et al.
Publicado: (2019)

Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer’s disease cases
por: Malarte, Mona-Lisa, et al.
Publicado: (2020)

(18)F-MK-6240 tau-PET in genetic frontotemporal dementia
por: Levy, Jake P, et al.
Publicado: (2021)

Optimizing quantification of MK6240 tau PET in unimpaired older adults
por: Harrison, Theresa M., et al.
Publicado: (2023)

In vivo quantification of neurofibrillary tangles with [(18)F]MK-6240
por: Pascoal, Tharick A., et al.
Publicado: (2018)

Cryo-EM structure of Alzheimer’s disease tau filaments with PET ligand MK-6240
por: Kunach, Peter, et al.
Publicado: (2023)

Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer’s disease, corticobasal degeneration and progressive supranuclear palsy brains
por: Malarte, Mona-Lisa, et al.
Publicado: (2022)

Visually Identified Tau (18)F-MK6240 PET Patterns in Symptomatic Alzheimer’s Disease
por: Krishnadas, Natasha, et al.
Publicado: (2022)

Plasma p217+tau versus NAV4694 amyloid and MK6240 tau PET across the Alzheimer's continuum
por: Doré, Vincent, et al.
Publicado: (2022)

Development, initial validation, and application of a visual read method for [(18)F]MK‐6240 tau PET
por: Shuping, Joanna L., et al.
Publicado: (2023)

Comparing tau status determined via plasma pTau181, pTau231 and [(18)F]MK6240 tau-PET
por: Tissot, Cécile, et al.
Publicado: (2022)

A multicenter comparison of [(18)F]flortaucipir, [(18)F]RO948, and [(18)F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosis
por: Leuzy, Antoine, et al.
Publicado: (2021)

Rates of regional tau accumulation in ageing and across the Alzheimer's disease continuum: an AIBL (18)F-MK6240 PET study
por: Krishnadas, Natasha, et al.
Publicado: (2023)

The Association of Age-Related and Off-Target Retention with Longitudinal Quantification of [(18)F]MK6240 Tau PET in Target Regions
por: Tissot, Cécile, et al.
Publicado: (2023)

A dual-time-window protocol to reduce acquisition time of dynamic tau PET imaging using [(18)F]MK-6240
por: Kolinger, Guilherme D., et al.
Publicado: (2021)

Phantom criteria for qualification of brain FDG and amyloid PET across different cameras
por: Ikari, Yasuhiko, et al.
Publicado: (2016)

Case Report: (18)F-MK6240 Tau Positron Emission Tomography Pattern Resembling Chronic Traumatic Encephalopathy in a Retired Australian Rules Football Player
por: Krishnadas, Natasha, et al.
Publicado: (2020)

Ethnic comparison of pharmacokinetics of (18)F-florbetaben, a PET tracer for beta-amyloid imaging, in healthy Caucasian and Japanese subjects
por: Senda, Michio, et al.
Publicado: (2014)

Japanese guideline for the oncology FDG-PET/CT data acquisition protocol: synopsis of Version 2.0
por: Fukukita, Hiroyoshi, et al.
Publicado: (2014)

Radiation dosimetry and pharmacokinetics of the tau PET tracer florzolotau (18F) in healthy Japanese subjects
por: Miyamoto, Masaomi, et al.
Publicado: (2023)

The role of radiolabeling in BNCT tracers for enhanced dosimetry and treatment planning
por: Mushtaq, Sajid, et al.
Publicado: (2023)

Development of matrix metalloproteinase-targeted probes for lung inflammation detection with positron emission tomography
por: Kondo, Naoya, et al.
Publicado: (2018)

Biodistribution and Dosimetry Evaluation for a Novel Tau Tracer [(18)F]-S16 in Healthy Volunteers and Its Application in Assessment of Tau Pathology in Alzheimer’s Disease
por: Wang, Ying, et al.
Publicado: (2022)

Human biodistribution and radiation dosimetry of the demyelination tracer [(18)F]3F4AP
por: Brugarolas, Pedro, et al.
Publicado: (2022)

Biodistribution and radiation dosimetry of multiple tracers on total-body positron emission tomography/computed tomography
por: Li, Lianghua, et al.
Publicado: (2023)

Dosimetry of [(18)F]TRACK, the first PET tracer for imaging of TrkB/C receptors in humans
por: Thiel, Alexander, et al.
Publicado: (2023)

The clinical safety, biodistribution and internal radiation dosimetry of flutemetamol ((18)F) injection in healthy Japanese adult volunteers
por: Senda, Michio, et al.
Publicado: (2015)

PET-Based Human Dosimetry of (68)Ga-NODAGA-Exendin-4, a Tracer for β-Cell Imaging
por: Boss, Marti, et al.
Publicado: (2020)

Radiation dosimetry of (18)F-AzaFol: A first in-human use of a folate receptor PET tracer
por: Gnesin, Silvano, et al.
Publicado: (2020)

Synthesis, preclinical evaluation and radiation dosimetry of a dual targeting PET tracer [(68)Ga]Ga-FAPI-RGD
por: Zang, Jie, et al.
Publicado: (2022)

Correction: Reynard, O.; et al. Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication. Viruses 2015, 7, 6233‒6240
Publicado: (2016)

[(11)C]Elacridar as a novel P-glycoprotein PET tracer, assessment of whole-body distribution and radiation dosimetry in humans
por: Bauer, Martin, et al.
Publicado: (2011)

Whole-Body Biodistribution, Dosimetry, and Metabolite Correction of [(11)C]Palmitate: A PET Tracer for Imaging of Fatty Acid Metabolism
por: Christensen, Nana L., et al.
Publicado: (2017)

Development of a New Positron Emission Tomography Tracer for Targeting Tumor Angiogenesis: Synthesis, Small Animal Imaging, and Radiation Dosimetry
por: Patterson, Cam, et al.
Publicado: (2013)

Antidepressant Effects of (+)-MK-801 and (-)-MK-801 in the Social Defeat Stress Model
por: Yang, Bangkun, et al.
Publicado: (2016)

The acid–base and redox properties of menaquinone MK-4, MK-7, and MK-9 (vitamin K(2)) in DMPC monolayers on mercury
por: Dharmaraj, Karuppasamy, et al.
Publicado: (2020)

Tau Filaments and the Development of Positron Emission Tomography Tracers
por: Goedert, Michel, et al.
Publicado: (2018)

Fusion dual-tracer SPECT-based hepatic dosimetry predicts outcome after radioembolization for a wide range of tumour cell types
por: Lam, Marnix G. E. H., et al.
Publicado: (2015)

Ridaforolimus (MK-8669) synergizes with Dalotuzumab (MK-0646) in hormone-sensitive breast cancer
por: Becker, Marc A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6s93iabftna1hlf3dcl2rd484l